Introduction
Submucosal exocrine glands secrete much of the fluid and mucus that hydrate the surfaces of cartilaginous airways in the lungs (1) . Serous acini are thought to be the primary site of fluid secretion, although the geometrical complexity and numerous cell types present in the glands have impeded investigations of the molecular mechanisms generating and regulating the volume and composition of the secreted fluid. Serous acinar cells express the CFTR anion channel (2) (3) (4) , which may play a role in fluid secretion elicited by agonists that raise intracellular [cAMP] ([cAMP] i ; refs. [5] [6] [7] [8] . Absence of this fluid secretion mechanism in cystic fibrosis (CF) may contribute to CF lung pathogenesis (9) .
Vasoactive intestinal polypeptide (VIP) belongs to the secretin family of peptides, which usually signal via Gα s -stimulated adenylyl cyclase-mediated elevation of [cAMP] i (10) . VIP receptors are expressed in submucosal gland acini, which lie in close proximity to VIP-containing neurons (reviewed in ref. 11 ). VIP elevates [cAMP] i in serous and mucous cells of ferret tracheal submucosal glands (12) and stimulates airway glycoprotein secretion (13) (14) (15) and CFTR-dependent fluid secretion from intact human, porcine, and murine submucosal glands (5) (6) (7) (8) . These secretory responses are mimicked by the adenylyl cyclase-activating compound forskolin (5, 7, 8, 16) . Gland fluid secretion is also elicited by cholinergic agonists, including carbachol (CCh). Strong cholinergic stimulation activates CFTR-independent secretion in human, porcine, and murine glands (6) (7) (8) . In porcine and murine serous cells, CChinduced secretion is intracellular Ca 2+ dependent and mediated in the same CFTR-expressing cells by a different Cl -channel, likely the Ca 2+ -activated Cl -channel (CaCC) Ano1 (TMEM16A; refs. 3, 4, and 17) . Smaller secretory responses evoked by submaximal cholinergic stimulation are potentiated by low VIP concentrations (10-100 nM) that are insufficient themselves to activate robust secretion in both human and pig glands (18) . Interestingly, this potentiation is CFTR dependent, suggesting that CFTR also plays a role in responses to submaximal cholinergic stimulation, but the molecular and cellular details of this synergism are not understood.
Despite their potential importance to CF pathology, the molecular mechanisms involved in serous acinar cell fluid secretion remain poorly defined. Here, we have examined cAMP-induced fluid secretion in porcine and human submucosal gland serous cells isolated from WT and CFTR KO (CFTR -/-) pigs and non-CF humans. Our results demonstrate that VIP stimulates fluid secretion by a CFTR-dependent mechanism requiring a concomitant cAMP-induced release of Ca 2+ from inositol trisphosphate-sensitive (InsP 3 -sensitive) intracellular stores and a rise of intracellular [Ca 2+ ] ([Ca 2+ ] i ). CFTR provides the secretory Cl -permeability, whereas the rise of [Ca 2+ ] i is necessary to activate plasma membrane K + permeabilities. Importantly, [Ca 2+ ] i responses to weak CCh stimulation that are insufficient to stimulate secretion are markedly potentiated by strong cAMP stimulation, resulting in robust cAMP-mediated CFTR-independent secretion and suggesting novel strategies to bypass the CFTR requirement for cAMPmediated fluid secretion. cine bronchial serous acinar cells with 1 μM VIP caused a 15% ± 2% cell shrinkage (within 107 ± 29 s; n = 7) that reversed upon washout ( Figure 1, A and B) . Similar cell volume changes during cholinergic stimulation result from changes in cell solute content associated with activation of ion channels and transporters that mediate fluid secretion (3, 4) . Shrinkage is caused by activation of apical membrane Cl -and/or basolateral membrane K + channels, resulting in KCl efflux; swelling is caused by activities of Na + -dependent Cl -uptake pathways in the basolateral membrane (3, 4) . In agreement, VIP-induced volume changes were temporally and quantitatively paralleled by changes in [Cl -] i ( Figure 1C and Supplemental Figure 1 ; supplemental material available online with this article; doi:10.1172/JCI42992DS1). Furthermore, swelling was inhibited by the Na + K + 2Cl -cotransporter (NKCC) inhibitor bumetanide and the Na + /H + exchanger (NHE) inhibitor dimethyl amiloride (Supplemental Figure 2) , indicating that NKCC1 and paired NHE and Cl -/HCO 3 -(anion) exchange (AE) mediate solute uptake, as shown for cholinergic-activated secretion by these cells (4) . Thus, VIP-induced cell volume changes report alterations in cell solute content reflecting changes in the secretory state of these cells (4). VIP-evoked shrinkage reflects solute efflux occurring upon activation of fluid secretion, while swelling reflects accumulation of solute via transporters that sustain secretion.
During cholinergic stimulation, cell volume closely tracks agonist-induced changes in [Ca 2+ ] i (4) . Surprisingly, VIP consistently caused a small rise in [Ca 2+ ] i , from 45 ± 7 nM at rest to a peak of 101 ± 12 nM (n = 7), that was temporally correlated with cell shrinkage (Figure 1, A and B) . Furthermore, relaxation of [Ca 2+ ] i toward resting levels was associated with cell swelling back to resting volume. The strong temporal correlation between dynamic [Ca 2+ ] i and volume changes was unexpected. While VIP has been linked to Ca 2+ signaling in some cell types (10, (19) (20) (21) (22) (23) (24) (25) , the mechanisms involved are unclear, and VIP has been assumed to activate airway gland fluid secretion solely by raising [cAMP] Figure 1F ). Responses remained intact in control cells (Figure 1G Figure 1C and Supplemental Figure 1 ). The phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX; 250 μM) also caused comparable shrinkage correlated with [Ca 2+ ] i elevation (Figure 1I) . No additive effects were observed between 250 μM IBMX and 1 μM VIP (discussed below), suggesting they both signal through cAMP, likely involving PKA. In agreement, the PKA inhibitor H89 completely abolished VIP-induced [Ca 2+ ] i elevation and shrinkage but had no effect on subsequent CCh-evoked responses ( Figure 1J ).
VIP-activated secretion requires CFTR. Fluid secretion elicited by VIP by intact glands requires CFTR. It has been assumed that VIP stimulates secretion solely by PKAmediated CFTR activation. However, our results suggest that serous cell secretion also requires cAMP-induced [Ca 2+ ] i signaling. Cholinergic stimulation of serous cell secretion similarly requires Ca 2+ signaling, but it is CFTR independent (3, 4, 17) . Nevertheless, the CFTR inhibitors GlyH-101 (26) and CFTR inh 172 (27) , which do not affect cholinergic-induced secretion (3, 4) , each inhibited VIP- or forskolin-activated shrinkage (Supplemental Figure 3 ). To examine the role of CFTR more directly, we isolated cells from neonatal porcine CFTR +/+ WT, and CFTR +/-heterozygote (Het), and CFTR -/-knockout tracheal submucosal glands (28) . CFTR -/-piglets develop significant CF-like lung disease within months after birth (29) , but neonatal CFTR -/-piglets are free of airway pathology (28, 29) , providing a model to directly compare CFTR -/-and isogenic WT littermates and examine effects of lack of CFTR in the absence of secondary pathology. Apical CFTR immunofluorescence was detected in ciliated epithelial cells ( Figure 2A ) and serous acini (Figure 2B ) from WT but not CFTR -/-tracheae. Serous cells from WT and Het piglets exhibited VIP- ( Figure 2C ) and forskolin-evoked ( Figure 2D -causes electroneutral exchange of cellular Cl -for NO 3 -, resulting in an increase in SPQ fluorescence. The rate of fluorescence increase can be used as a measure of relative plasma membrane anion permeability.
SPQ-loaded serous cells were loaded with BAPTA and stimulated in 0-Ca 2+ o , conditions that eliminated the [Ca 2+ ] i signal and secretion (as in Figure 1F ). Experiments were performed in the presence of bumetanide and absence of CO 2 /HCO 3 -to eliminate NKCC- and AE-mediated Cl -transport, respectively. In the absence of stimulation, introduction of NO 3 -slowly enhanced SPQ fluorescence (Figure 3 , A and B), suggesting low resting anion permeability. VIP (1 μM; Figure 3 , A and B) or forskolin (10 μM; Supplemental Figure 5 ) enhanced the rate of SPQ fluorescence change by 10-fold (rates summarized in Supplemental Figure 5 ). Thus, VIP/cAMP activates a plasma membrane anion permeability in the absence of a rise of [Ca 2+ ] i . VIP-stimulated Cl -permeability was strongly inhibited by GlyH-101 and CFTR inh 172 (P < 0.01; Figure 3B ), but not by the CaCC inhibitor niflumic acid (NFA; Figure 3B ) (32) . This suggests that VIP activates a cAMP- and CFTR-dependent, Ca 2+ -independent anion permeability. Similar experiments were performed using serous cells from transgenic piglets. Basal unstimulated Cl -permeabilities ( Figure 4A ), as observed previously (4). This [Ca 2+ ] i elevation is of similar magnitude to that elicited by VIP, but in contrast to VIP, it was insufficient to stimulate secretion ( Figure 4A ). 100 nM CCh failed to enhance plasma membrane Cl -permeability in any of 40 serous cells and acini examined (Supplemental Figure 5 , J-K). Thus, the [Ca 2+ ] i elevation expected to occur in approximately 40% of these cells is insufficient to activate CaCC. Therefore, the Ca 2+ dependence of cAMP-induced secretion involves CFTR-independent mechanisms having Ca 2+ sensitivities higher than CaCC.
Low [VIP] potentiates CFTR-dependent
Lower [VIP] (100 nM) caused a small sustained elevation of [Ca 2+ ] i that failed to activate secretion ( Figure 4B ). However, subsequent addition of 100 nM CCh, itself also insufficient to stimulate secretion ( Figure 4A ), consistently induced robust shrinkage (14% ± 3%) in 100% of cells (n = 6; Figure 4B ). Of interest, the peak [Ca 2+ ] i elicited by combined exposure to 100 nM VIP and 100 nM CCh (130 ± 5 nM; n = 6) was similar to that elicited by 100 nM CCh alone (Figure 4 , A and G) and still smaller than that required to activate secretion with (higher concentrations of) CCh alone (3, 4) . 100 nM VIP similarly enhanced the number of cells exhibiting [Ca 2+ ] i responses to 100 nM CCh in WT, Het, and CFTR -/-neonatal tracheal serous cells (Figure 4 , C-E). Robust shrinkage was observed in WT (21% ± 1% within 50.4 ± 3 s; n = 10; Figure 4C ) and Het cells (19% ± 2% within 67 ± 6 s; n = 12; magnitude NS but time P < 0.05 compared with WT; Figure 4D ). In contrast, shrinkage was absent in CFTR -/-cells ( Figure 4E) . Thus, the synergistic secretory effects of 100 nM VIP plus 100 nM CCh require CFTR. As 100 nM VIP enhanced Cl -permeability approximately 10-fold in WT cells (Supplemental Figure 5) Figure 5D ). 2+ -independent activation of CFTR. To determine whether the results obtained from the porcine models are relevant for human submucosal gland physiology, we isolated serous acinar cells from nasal turbinates obtained from non-CF individuals. The inferior nasal turbinates are rich in submucosal glands, which secrete copious amounts of fluid and mucus to humidify inspired air and trap particles and pathogens. Functional and histological studies have not revealed any significant differences between nasal submucosal glands and those found in lower airways (16, (33) (34) (35) (36) (37) , and intact human nasal glands also exhibit CFTR-dependent fluid secretion in response to [cAMP] i -elevating agonists (16, 37) .
Human nasal serous cells exhibit VIP-evoked cAMP-and Ca 2+ -dependent cell shrinkage requiring Ca
Human nasal serous acinar cells exhibited highly similar secretory responses to 1 μM VIP compared with porcine cells (Figure 6A Both VIP-evoked [Ca 2+ ] i elevation and CFTR-dependent shrinkage were inhibited by H89, suggesting that both responses are downstream of PKA ( Figure 6D) . Inhibition of the cAMP-dependent [Ca 2+ ] i response by depletion of Ca 2+ stores ( Figure 6E ) or BAPTA buffering ( Figure 6F ) each eliminated VIP-evoked shrinkage in human cells. Taken together, these data suggest that human serous cell shrinkage is caused by KCl efflux through CFTR and Ca 2+ -activated K + channels, as in porcine cells. To more directly determine whether the requirement for Ca 2+ was independent of that for activation of CFTR, we performed NO 3 -substitution experiments to examine VIP-evoked changes in anion permeability under Ca 2+ -buffered conditions, exactly as described for porcine cells (Figure 3) . Average traces from independent experiments are shown in Figure 6G . Upon NO 3 -substitution, SPQ fluorescence increased by 0.001 ΔF/F (t=0) units × s -1 in unstimulated (control) cells (n = 11). This rate was increased 15-fold by 1 μM VIP (0.015 ± 0.002 units × s -1 ; n = 9; P < 0.01 compared with control by Dunnett's test), 100 nM VIP (0.013 ± 0.004 units × s -1 ; n = 7; P < 0.01 compared with control by Dunnett's test; NS compared with 1 μM VIP), or 10 μM forskolin (0.015 ± 0.003 units × s -1 ; n = 7; P < 0.01 compared with control by Dunnett's test; NS compared with 1 μM or 100 nM VIP). CFTR inh 172, which inhibited VIP-evoked shrinkage, markedly reduced the VIP-activated rate of SPQ unquenching upon NO 3 -substitution (0.0018 ± 0003 units × s -1 ; n = 10; P < 0.01 compared with 1 μM or 100 nM VIP; P < 0.05 compared with control cells by Dunnett's test). In contrast, NFA had no significant effect (ΔF/F (t=0) = 0.017 ± 0.003, n = 11; NS compared with 1 μM or 100 nM VIP; P < 0.01 compared with control by Dunnett's test). These data (summarized in Figure  6H ) demonstrate that VIP activates a cAMP- and CFTR-dependent, Ca 2+ -independent plasma membrane anion permeability, similar to that observed in porcine serous cells. Accordingly, the dependence of shrinkage on VIP-induced Ca 2+ signaling is likely due to a requirement for activation of Ca 2+ -activated K + permeabilities. Figure 7A ) that were similar in magnitude to those evoked by 1 μM VIP yet, unlike VIP, were nonetheless insufficient to activate secretion ( Figure 6 ). However, after exposure to low [VIP] (100 nM, which had minimal effects on [Ca 2+ ] i and no effect on cell volume), 100 nM CCh evoked significant shrinkage (16% ± 2% within 85 ± 6 s in 100% of cells; n = 7; Figure 7B ), despite no potentiation of the [Ca 2+ ] i response (128 ± 8 nM; NS compared with 100 nM CCh alone). This shrinkage was completely inhibited by CFTR inh 172 ( Figure  7C ; n = 6) despite identical [Ca 2+ ] i responses (125 ± 5 nM). In contrast, neither shrinkage (17% ± 1% within 88 ± 10 s) nor peak [Ca 2+ ] i (132 ± 8 nM) were affected by NFA ( Figure 7D ; n = 5; both values NS compared with 100 nM VIP plus 100 nM CCh). These data suggest that the mechanisms of CFTR-dependent synergy between low [VIP] and weak cholinergic stimulation observed in porcine serous cells (Figure 4 ) are present similarly in human serous cells.
Strong cAMP stimulation can elicit CFTR-independent fluid secretion in
To determine whether strong cAMP stimulation enables lowlevel cholinergic stimulation to evoke CFTR-independent secretion, as in the porcine cells, human cells were exposed to a higher [VIP] (1 μM) before stimulation with 100 nM CCh. CCh-evoked Figure 7F ). However, shrinkage was completely abolished by NFA ( Figure 7G ) despite an identical peak Ca 2+ response (356 ± 20 nM; n = 5). Stimulation with 5 μM forskolin ( Figure 7H ; n = 4) or 100 μM IMBX ( Figure 7I ; n = 5) likewise potentiated 100 nM CCh-evoked [Ca 2+ ] i responses (346 ± 12 nM and 325 ± 18 nM, respectively; NS) and activated robust CFTRindependent shrinkage (20% ± 2% within 62 ± 14 s and 20% ± 1% within 58 ± 9 s, respectively; NS compared with each other or with 1 μM VIP plus 100 nM CCh in the presence of CFTR inh 172 plus GlyH-101). These results suggest that porcine and human serous cells share similar mechanisms of Ca 2+ -dependent CFTR-independent synergistic secretion during strong cAMP stimulation and low-level cholinergic stimulation.
Discussion
Here we have isolated primary serous acinar cells from porcine lung and human nasal turbinates to identify the mechanisms and regulation of cAMP-mediated fluid secretion, exploiting the availability of CFTR -/-pigs and pharmacological inhibitors to evaluate the role of CFTR. Porcine and human serous cells secrete fluid in response to VIP and other agents that raise [cAMP] i by mechanisms requiring CFTR and, unexpectedly, also a rise of [Ca 2+ ] i (summarized in Figure 8 ). The cAMP-mediated [Ca 2+ ] i signals involve release from InsP 3 -sensitive Ca 2+ stores that are shared by cAMP-independent agonists including cholinergic, histaminergic, and purinergic agonists that stimulate CFTR-independent secretion (4). The shared [Ca 2+ ] i signaling mechanisms between these distinct pathways provide 2 types of synergisms that strongly potentiate cAMP-mediated fluid secretion but differ in their CFTR dependencies. First, CFTR-dependent secretion is markedly potentiated by low VIP and CCh concentrations that individually are unable to stimulate secretion. Second, a higher [VIP] more strongly potentiates secretion by a low [CCh] that is unable to activate secretion alone. Importantly, this cAMP-potentiated secretion is CFTR independent, which therefore suggests novel therapeutic approaches for CF. Additionally, our data demonstrate that the mechanisms of fluid secretion and the role of CFTR in porcine and human serous cells are very similar, suggesting that WT and CFTR -/-pigs are a physiologically relevant model in which to study CFTR-dependent airway fluid secretion.
VIP activates cAMP-dependent Cl -efflux through CFTR. Exposure of serous cells to VIP caused marked changes in cell volume. Similar responses were elicited by direct cAMP elevation (forskolin, IBMX) and inhibited by H89, suggesting that they are downstream of cAMP and PKA. As shown previously during CCh stimulation (3, 4) , these cell volume changes track changes in solute content associated with activities of transport mechanisms involved in fluid secretion. First, these volume changes were associated with parallel changes in [Cl -] i . Second, shrinkage was inhibited by CFTR inhibitors and was absent in CFTR -/-cells. Third, swelling of porcine cells was inhibited by blockers of Na + -dependent Cl -influx pathways. Thus, VIP-induced shrinkage and swelling reflect solute efflux and influx, respectively. The observed approximate 15% shrinkage reflects an approximately 21% decrease in osmotically active cell volume (3, 4, 38) . Using the relationship between [Cl -] i and serous cell volume ( Figure 1C ), [Cl -] i falls from approximately 65 mM at rest to approximately 39 mM at peak shrinkage, reflecting a loss of approximately 32 meq/l cellular Cl -content. Assuming equal counter-ion (K + ) efflux, approximately 64 meq of cell solute content is lost, in good agreement with approximately 63 meq expected for 21% shrinkage of osmotically active volume in 300 mOsm medium. Because VIP-stimulated Cl -efflux is completely CFTR dependent and CFTR is apically localized (Figure 2 and ref. 4) , the Cl -loss during shrinkage reflects Cl -secretion through CFTR. The counter-ion K + efflux was not localized here, but must occur across the basolateral membrane through mechanisms remaining to be identified. Inhibition of swelling by bumetanide and DMA suggests that Cl -uptake is mediated by both NKCC1 and paired NHE/AE activity located on the basolateral membrane, similar to the mechanism proposed for CCh-evoked secretion (4). Together, activities of these pathways constitute a mechanism for fluid secretion, and cell volume changes reflect the secretory activities of these cells (3, 4, 38) . The absence of cAMP-evoked secretion from CFTR -/-porcine serous cells and the GlyH-101 and CFTR inh 172 sensitivities of cAMP-evoked secretion in WT porcine and human cells demonstrate that cAMP-induced serous cell secretion is CFTR dependent, in agreement with results obtained from intact glands (5, 6, 8, 39) . Despite the complexity of glands containing multiple cell types, the concordant results suggest that the serous cell mechanisms defined here contribute predominantly to the intact gland responses. In contrast, CCh-evoked secretion from WT (4) and CFTR -/-(this study) porcine serous cells, human nasal serous cells, and from intact glands (8, 40) is largely CFTR independent and inhibited by NFA. It has been speculated that CCh/Ca 2+ -evoked and VIP/cAMP-evoked fluid secretion may originate from separate populations of gland cells (9) , but our results demonstrate that 2 separate secretion pathways exist in the same serous cells, mediated by either CFTR or CaCC.
VIP (41) . PKA phosphorylation of resident InsP 3 Rs could sensitize them to the basal [InsP 3 ] i , generating a Ca 2+ response in the absence of de novo InsP 3 production, and also augment InsP 3 R sensitivity to low [InsP 3 ] i produced during 100 nM CCh stimulation. While the predominant InsP 3 R isoform or isoforms in serous cells are unknown, all 3 isoforms can be phosphorylated by PKA in intact cells (41) . Further work is required to identify the molecular mechanisms of crosstalk between Ca 2+ and cAMP signaling in these cells.
An important yet surprising observation was that these Ca 2+ signals were required for cAMP-activated secretion. While the Ca 2+ -mobilizing agonist CCh has been shown to influence VIPinduced CFTR-dependent secretion (18) It has been proposed that airway inflammation expands InsP 3 -sensitive Ca 2+ stores, leading to exaggerated Ca 2+ release in response to InsP 3 -generating agonists (42) . We observed no enhancement of InsP 3 -activated Ca 2+ release in porcine CFTR -/-serous cells, but they were obtained from disease-free neonatal lungs. Ca 2+ store expansion with CF disease progression could possibly result in enhanced Ca 2+ release in response to low-level cholinergic stimulation that could activate CFTR-independent secretion. Furthermore, our results suggest that inflammatory mediators that elevate cAMP could enhance low-level cholinergic-evoked Ca 2+ responses and promote CFTR-independent secretion. Whether such responses exist and whether they would be beneficial or exacerbate lung pathology are unknown. The lungs of CFTR -/-pigs spontaneously develop substantial CF-like airway inflammation and pathology over several months (29) . It may therefore be possible to test these ideas in future studies.
Methods
Reagents and experimental solutions. VIP was obtained from Advanced ChemTech/CreoSalus or Sigma-Aldrich. Alexa Fluor (AF) secondary antibodies, fura-2-AM, SPQ, BAPTA-AM, and SNARF-5F-AM were purchased from Invitrogen. Collagenase and DNase I were obtained from Worthington Biochemical. Cell-Tak was purchased from BD Biosciences. Vectashield mounting medium was purchased from Vector Labs. All other reagents were from Sigma-Aldrich.
The primary extracellular solution (solution A) contained 125 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 1.2 mM CaCl2, 1.2 mM NaH2PO4, 11 mM glucose, and 25 mM NaHCO3 -buffered to pH 7.4 by 95% O2/5% CO2 gassing (3, 4, 17) . Experiments performed in the absence of extracellular Ca 2+ (0-Ca 2+ o) employed CaCl2-free solution A plus 1 mM EGTA. Dissection of tissue and gland isolation (as described in ref. 4 ) utilized buffer lacking NaHCO3 -and containing 20 mM HEPES, 2 mM l-glutamine, 1× penicillin/streptomycin, 50 μg/ml gentamicin, and 1× MEM vitamins, amino acids, and nonessential amino acids (solution B). Tissue was transported to the lab at approximately 4°C in solution B plus 1 μM indomethacin (7) . or from a local abattoir (Hatfield Quality Meats, Hatfield, Pennsylvania, USA) within 10 minutes after death. No differences were observed between cells isolated from either source. Neonatal porcine tracheae from pigs 24 to 48 hours old (n = 7 WT, 6 Het, and 5 CFTR -/-) were provided by M.J. Welsh and P.H. Karp (University of Iowa, Iowa City, Iowa, USA). Whenever possible, CFTR -/-cells were compared directly with cells from WT and Het littermates. All procedures were approved by the University of Pennsylvania Institutional Animal Care and Use Committee. Serous cells were isolated by incubation of dissected submucosal glands in types 2 and 4 collagenases (1 mg × ml -1 each) and DNAse I (10 μg × ml -1 ) for approximately 40 minutes at room temperature as described (4) . After gentle centrifugation, cells were resuspended in either solution A or solution C, plated on Cell-Tak coated coverslips, and imaged within 6-8 hours after isolation.
Isolation of human nasal submucosal gland serous acinar cells. Human inferior turbinate was provided by N.A. Cohen, J.N. Palmer, A.G. Chiu, and D.W. Kennedy and L. Doghramji (Department of Otorhinolaryngology, University of Pennsylvania and Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA). Tissue was obtained with approval of the University of Pennsylvania Institutional Review Board and written consent from 9 non-CF adult patients undergoing turbinectomy procedures related to chronic sinusitis and/or allergic rhinitis. Tissue was transported to the lab in ice-cold PBS. Epithelium was cut from the bone in ice-cold solution B and either used directly or stored at 4°C as described above. The dense connective tissue underlying the turbinate epithelium necessitated a stronger digestion protocol. Gland-rich submucosal tissue was dissected away from surface epithelium and incubated for 1.5 hours in types 2 and 4 collagenases (2 mg × ml -1 each) and 10 μg × ml -1 DNase I. After washing, cells were plated on coverslips and imaged within approximately 6 hours. No detectable differences were observed in the responses of cells isolated from different individuals; all responses were very similar to those observed in porcine serous cells (this study and ref. 4) . Nonetheless, all results were confirmed using at least 2 different cell preparations on separate days using tissue from different individuals.
Simultaneous DIC/fluorescence live cell imaging. Serous cells were loaded with fura-2 by incubation in 2 μM fura-2-AM for 10 minutes at room temperature. Cells were loaded with SPQ by approximately 1- to 2-hour incubation in 20 mM SPQ. Simultaneous DIC and fluorescence imaging of cells and small acini was performed as described (3, 38, 43) . Cells were typically imaged immediately after loading, but loaded cells remained viable on coverslips for more than 45 minutes. Conversions of fura-2 340 nm/380 nm ratios to [Ca 2+ ]i and conversion of SPQ fluorescence changes to [Cl -]i were performed as described (3, 4, 38) . Relative cell/acini volume changes were determined by raising the DIC-imaged cross-sectional area to the 3/2 power (3, 4, 17, 38, 43) . All experiments were performed at 37°C.
Confocal immunofluorescence microscopy. Immunocytochemistry was performed as described (3, 4, 17) using anti-CFTR mouse monoclonal antibody 24-1. Briefly, plated cells were fixed for 20 minutes in 4% formaldehyde in PBS (+Ca 2+ , +Mg 2+ ) at room temperature. Permeabilization and primary antibody incubation were performed in PBS (+ 2% BSA, 2% goat serum, and 0.1% saponin) overnight at 4°C. Following washing, coverslips were incubated in PBS plus BSA/serum/saponin containing AF488-conjugated secondary antibody for 1-2 hours at 4°C. Coverslips were mounted using Vectashield mounting medium and imaged on an inverted Nikon microscope (×60, 1.4 NA objective) equipped with a PerkinElmer Ultraview confocal system. Identical microscope (objective, laser power) and camera (exposure, gain, binning) settings were used to image WT and CFTR -/-cells.
Software and statistical analysis. Images were acquired using Ultraview software (PerkinElmer). Data were analyzed using Excel (Microsoft), Igor Pro (WaveMetrics Inc.), and/or ImageJ (W. Rasband, NIH). Unless indicated, all values are represented as mean ± SEM. Two-tailed Student's t test (Excel) was used to determine statistical significance (P value) unless indicated otherwise. When indicated, 2-tailed Dunnett's test (Igor Pro) was used. P < 0.05 was considered significant.
